CICI
GMED icon

Capital Investment Counsel Inc’s Globus Medical GMED Stock Holding History

Capital Investment Counsel Inc’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.57M Sell
19,890
-1,000
-5% -$85K 0.17% 69
2026
Q1 		$1.8M Hold
20,890
– – 0.22% 61
2025
Q4 		$1.82M Hold
20,890
– – 0.21% 63
2025
Q3 		$1.2M Sell
20,890
-1,100
-5% -$63.3K 0.15% 81
2025
Q2 		$1.3M Sell
21,990
-500
-2% -$32.3K 0.17% 76
2025
Q1 		$1.65M Buy
22,490
+200
+0.9% +$16.5K 0.25% 61
2024
Q4 		$1.84M Sell
22,290
-1,300
-6% -$103K 0.28% 56
2024
Q3 		$1.69M Hold
23,590
– – 0.24% 59
2024
Q2 		$1.62M Buy
23,590
+100
+0.4% +$5.97K 0.24% 60
2024
Q1 		$1.26M Buy
23,490
+3,000
+15% +$161K 0.22% 68
2023
Q4 		$1.09M Buy
20,490
+8,000
+64% +$390K 0.19% 78
2023
Q3 		$620K Hold
12,490
– – 0.12% 97
2023
Q2 		$744K Buy
12,490
+200
+2% +$11.4K 0.14% 87
2023
Q1 		$696K Sell
12,290
-600
-5% -$38.5K 0.16% 91
2022
Q4 		$957K Buy
12,890
+1,450
+13% +$98.7K 0.23% 75
2022
Q3 		$681K Sell
11,440
-2,250
-16% -$135K 0.2% 85
2022
Q2 		$769K Hold
13,690
– – 0.19% 83
2022
Q1 		$1.01M Sell
13,690
-1,800
-12% -$125K 0.21% 78
2021
Q4 		$1.12M Hold
15,490
– – 0.21% 76
2021
Q3 		$1.19M Hold
15,490
– – 0.26% 67
2021
Q2 		$1.2M Buy
15,490
+200
+1% +$14.2K 0.27% 65
2021
Q1 		$943K Buy
15,290
+520
+4% +$32.9K 0.25% 68
2020
Q4 		$963K Sell
14,770
-1,450
-9% -$83.4K 0.3% 58
2020
Q3 		$803K Buy
16,220
+2,450
+18% +$126K 0.24% 59
2020
Q2 		$657K Sell
13,770
-1,950
-12% -$94.1K 0.25% 66
2020
Q1 		$669K Sell
15,720
-2,400
-13% -$119K 0.27% 66
2019
Q4 		$1.07M Hold
18,120
– – 0.34% 55
2019
Q3 		$926K Buy
+18,120
New +$863K 0.33% 63

Other funds holding GMED

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

Capital Investment Counsel Inc's GMED Position: Q2 2026 in Review

Capital Investment Counsel Inc reduced its Globus Medical (GMED) stake by 4.8% in Q2 2026, selling an estimated $85K and leaving 19,890 shares worth $1.57M. The position accounts for 0.17% of the portfolio, ranked #69.

Capital Investment Counsel Inc first reported a position in GMED in Q3 2019 and has held it in 28 quarters since. The position peaked at $1.84M in Q4 2024. 274 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Capital Investment Counsel Inc held 19,890 shares of Globus Medical worth $1.57M as of Q2 2026.
  • Capital Investment Counsel Inc sold 1,000 Globus Medical shares in Q2 2026, an estimated $85K.
  • Globus Medical made up 0.17% of Capital Investment Counsel Inc's portfolio in Q2 2026, its #69 holding.
  • Capital Investment Counsel Inc first reported a position in Globus Medical in Q3 2019 and has held it in 28 quarters since.
  • Capital Investment Counsel Inc's Globus Medical position peaked at $1.84M in Q4 2024.
  • 274 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Capital Investment Counsel Inc's 13F filing for Q2 2026, filed 27 Jul 2026.